Aimwell Partners unit Aimwell Bio acquires Trustr behavioral engagement IP portfolio from inventor Jones

• Aimwell Partners announced Aimwell Bio executed a definitive IP Purchase and Assignment Agreement to acquire the Trustr behavioral engagement portfolio.
• Deal transfers a patent family, software, machine-learning models, trade secrets, trademarks, and related know-how from inventor Dr. Christopher A. Jones.
• Consideration will be paid via restricted shares of Aimwell Bio common stock; no cash consideration is payable.
• Company plans to add platform contributors and advisors, disclosing names only as individual agreements are signed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimwell Partners Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608270830ACCESSWRNAPR_____1213197) on August 27, 2026, and is solely responsible for the information contained therein.